Dr. Lal PathLabs Ltd
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
01 / The disclosure
What the company shared
Attached
A question for your research
Check transaction size, funding, dilution, approvals and completion conditions before assessing the earnings impact.
The evidence
Read the source excerpts
01Sub: Update on Acquisition of stake in SN Genelab Private Limited Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Listing Regulations”)
Page 1
02With reference to the captioned subject and in continuation to our earlier intimation dated September 24, 2026, wherein we have informed that the Board of Directors of the Company has approved for acquisition of stake in SN Genelab Private Limited (“SN Gene”).
Page 1
03We wish to inform you that the Company has completed the said acquisition on October 01, 2026, as per the terms and conditions of the Agreement.
Page 1
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- ff0473ae-3f26-4a34-b18d-83d076eb9cb5
- First collected
- 3 Oct 2026, 17:18 IST
- PDF extraction
- extracted · 1 pages read
- Extraction note
- Source excerpts; financial tables have not been validated.
- Document SHA-256
- c3765043feda054fd2cfa029c78a03eb941240911eb344a3f8e4e5bf4038cc5d